Orphan endogenous lipids and orphan GPCRs: A good match

被引:30
作者
Bradshaw, Heather B. [1 ]
Lee, Sung Ha [1 ]
McHugh, Douglas [1 ]
机构
[1] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA
关键词
Lipoamino acids; N-Acyl amides; Cannabinoids; N-Arachidonoyl glycine; Farnesyl pyrophosphate; N-Palmitoyl glycine; PROTEIN-COUPLED RECEPTOR; NEUROPEPTIDE HEAD ACTIVATOR; N-ARACHIDONYL-GLYCINE; CANNABINOID RECEPTOR; BRAIN CONSTITUENT; CB2; RECEPTORS; IDENTIFICATION; ANANDAMIDE; LIGAND; PAIN;
D O I
10.1016/j.prostaglandins.2009.04.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
A large and growing family of over 70 endogenous lipids of the basic structure N-acyl amide has been identified during the last 10 years. Only a few of these lipids have been characterized for biological activity. however, those that have shown a wide-range of activity may act at G-protein coupled receptors (GPCRs). Like orphan GPCRs that are identified as being in the genome and expressed in tissue, the majority of these endogenous lipids many produced throughout the body, some predominately in nervous tissue, remain orphaned. Here, we give a brief history of these orphan lipids and highlight the activity of N-arachidonoyl glycine, and farnesyl pyrophosphate at the orphan receptors GPR18 and GPR92, respectively, as well as summarizing the biological and pharmacological data for the recently identified N-palmitoyl glycine that suggests activity at a novel GPCR. Working to deorphanize both lipids and GPCRs together provides a unique opportunity for a greater understanding of cellular signaling and a challenge to find them all a home. Published by Elsevier Inc.
引用
收藏
页码:131 / 134
页数:4
相关论文
共 45 条
[1]
Boels K, 2001, J CELL SCI, V114, P3599
[2]
Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance [J].
Borrelli, Francesca ;
Izzo, Angelo A. .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (01) :33-49
[3]
The expanding field of cannabimimetic and related lipid mediators [J].
Bradshaw, HB ;
Walker, JM .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (04) :459-465
[4]
BRADSHAW HB, 2009, VITAM HARM, V81
[5]
Burstein S., 1997, S CANN INT CANN RES, P31
[6]
Oxidative metabolism of anandamide [J].
Burstein, SH ;
Rossetti, RG ;
Yagen, B ;
Zurier, RB .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 61 (1-2) :29-41
[7]
Regulation of anandamide tissue levels by N-arachidonylglycine [J].
Burstein, SH ;
Huang, SM ;
Petros, TJ ;
Rossetti, RG ;
Walker, JM ;
Zurier, RB .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (07) :1147-1150
[8]
N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia [J].
Chu, CJ ;
Huang, SM ;
De Petrocellis, L ;
Bisogno, T ;
Ewing, SA ;
Miller, JD ;
Zipkin, RE ;
Daddario, N ;
Appendino, G ;
Di Marzo, V ;
Walker, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) :13633-13639
[9]
ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[10]
Targeting the endocannabinoid system: to enhance or reduce? [J].
Di Marzo, Vincenzo .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (05) :438-455